05.08.2013 - India has revoked a patent granted to GlaxoSmithKline for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
